Harte-Hanks
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Harte-Hanks with three of four analysts rating it hold. Analysts don't like Harte-Hanks as much as competitor ValueClick overall. Seven out of 16 analysts rate ValueClick a buy compared to one of four for Harte-Hanks. Analysts still rate the stock a Hold, but they are a bit more wary about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $209 million in revenue this quarter. That would represent a rise of 0.7% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.17 per share. Estimates range from $0.16 to $0.18.
What our community says:
CAPS All Stars are solidly backing the stock with 83.3% granting it an "outperform" rating. The community at large backs the All Stars with 79.4% assigning it a rating of "outperform." Fools are keen on Harte-Hanks, though the message boards have been quiet lately with only 28 posts in the past 30 days. Harte-Hanks' bearish CAPS rating of two out of five stars falls short of the Fool community sentiment.
Management:
Harte-Hanks' income has fallen year over year by an average of 2.4%. Revenue has now gone up for three straight quarters.
Quarter | Q1 | Q4 | Q3 | Q2 |
Gross Margin | 61.9% | 61.6% | 62.6% | 62.2% |
Operating Margin | 7.1% | 10.6% | 11.6% | 10.9% |
Net Margin | 4% | 6.6% | 6.4% | 6.5% |
For all our Harte-Hanks-specific analysis, including earnings and beyond, add Harte-Hanks to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.